These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1211674)

  • 1. [Prognostic factors in idiopathic myeloid splenomegaly].
    Vorhauer-Atlan W; Briere J; Jacquillat C; Najean Y; Laval-Jeantet M; Chelloul N
    Ann Anat Pathol (Paris); 1975; 20(3):259-76. PubMed ID: 1211674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of myeloid metaplasia with myelofibrosis.
    Chelloul N; Briere J; Laval-Jeantet M; Najean Y; Vorhauer W; Jacquillat C
    Biomedicine; 1976; 24(4):272-80. PubMed ID: 990377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of bone and bone marrow lesions of primary myeloid metaplasia].
    Chelloul N; Jacquillat C; Brière J; Laval-Jeantet M; Vorhauer-Atlan W
    Nouv Presse Med; 1975 Dec; 4(43):3060-2. PubMed ID: 1223788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
    Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
    Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic myelofibrosis: a retrospective study of 103 patients.
    Anger B; Seidler R; Haug U; Popp C; Heimpel H
    Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cryptogenetic myeloid splenomegaly (study of 49 cases)].
    Gallais H; Casanova P; Muratore R; Olmer J
    Mars Med; 1971; 108(6):409-23. PubMed ID: 5116732
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
    Dupriez B; Demory JL
    Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
    Lazăr D; Tăban S; Dema A; Cornianu M; Goldiş A; Raţiu I; Sporea I
    Rom J Morphol Embryol; 2009; 50(1):41-50. PubMed ID: 19221644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival rate and prognostic factors in patients with intestinal failure.
    Vantini I; Benini L; Bonfante F; Talamini G; Sembenini C; Chiarioni G; Maragnolli O; Benini F; Capra F
    Dig Liver Dis; 2004 Jan; 36(1):46-55. PubMed ID: 14971815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].
    Bettini R; Redaelli S; Marzetta K; Maino C; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2004; 95(7-8):358-64. PubMed ID: 15303545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease with bone marrow involvement.
    Gupta R; Parikh PM; Advani SH; Charak BS; Saikia T; Dinshaw KA; Gonsalves MA; Gopal R; Nair CN; Nadkarni KS
    Indian J Cancer; 1989 Jun; 26(2):58-66. PubMed ID: 2591999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenomegalic pancytopenia of probable immune origin: cure after treatment with glucocorticoids].
    Fuentes A; Feliu E; Blade J; Campo E; Ribera JM; Cervantes F; Rozman C
    Med Clin (Barc); 1996 Feb; 106(7):263-6. PubMed ID: 8667677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of bone marrow fibrosis in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.